Abstract
Atherogenic dyslipidemia (AD) is a common feature in persons with premature coronary heart disease. While several linkage studies have been carried out to dissect the genetic etiology of lipid levels, few have investigated the AD lipid triad comprising elevated serum triglyceride, small low density lipoprotein (LDL) particles, and reduced high density lipoprotein (HDL) cholesterol levels. Here we report the results of a whole-genome screen for AD using the Framingham Heart Study population. Our analyses provide some evidence for linkage to AD on chromosomes 1q31, 3q29, 10q26, 14p12, 14q13, 16q24, 18p11, and 19q13. AD susceptibility is modulated by multiple genes in different chromosomes. Our study confirms results from other populations and suggests new areas of potential importance.
Cite
CITATION STYLE
Yip, A. G., Ma, Q., Wilcox, M., Panhuysen, C. I., Farrell, J., Farrer, L. A., & Wyszynski, D. F. (2003). Search for genetic factors predisposing to atherogenic dyslipidemia. BMC Genetics, 4 Suppl 1. https://doi.org/10.1186/1471-2156-4-s1-s100
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.